» Articles » PMID: 26071549

Aerobic Exercise Training Promotes Physiological Cardiac Remodeling Involving a Set of MicroRNAs

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Left ventricular (LV) hypertrophy is an important physiological compensatory mechanism in response to chronic increase in hemodynamic overload. There are two different forms of LV hypertrophy, one physiological and another pathological. Aerobic exercise induces beneficial physiological LV remodeling. The molecular/cellular mechanisms for this effect are not totally known, and here we review various mechanisms including the role of microRNA (miRNA). Studies in the heart, have identified antihypertrophic miRNA-1, -133, -26, -9, -98, -29, -378, and -145 and prohypertrophic miRNA-143, -103, -130a, -146a, -21, -210, -221, -222, -27a/b, -199a/b, -208, -195, -499, -34a/b/c, -497, -23a, and -15a/b. Four miRNAs are recognized as cardiac-specific: miRNA-1, -133a/b, -208a/b, and -499 and called myomiRs. In our studies we have shown that miRNAs respond to swimming aerobic exercise by 1) decreasing cardiac fibrosis through miRNA-29 increasing and inhibiting collagen, 2) increasing angiogenesis through miRNA-126 by inhibiting negative regulators of the VEGF pathway, and 3) modulating the renin-angiotensin system through the miRNAs-27a/b and -143. Exercise training also increases cardiomyocyte growth and survival by swimming-regulated miRNA-1, -21, -27a/b, -29a/c, -30e, -99b, -100, -124, -126, -133a/b, -143, -144, -145, -208a, and -222 and running-regulated miRNA-1, -26, -27a, -133, -143, -150, and -222, which influence genes associated with the heart remodeling and angiogenesis. We conclude that there is a potential role of these miRNAs in promoting cardioprotective effects on physiological growth.

Citing Articles

Exercise mediates myocardial infarction via non-coding RNAs.

Han C, Zhai C, Li A, Ma Y, Hallajzadeh J Front Cardiovasc Med. 2024; 11:1432468.

PMID: 39553846 PMC: 11563808. DOI: 10.3389/fcvm.2024.1432468.


Circulating miRNA Signaling for Fatty Acid Metabolism in Response to a Maximum Endurance Test in Elite Long-Distance Runners.

Paulucio D, Ramirez-Sanchez C, Velasque R, Xavier R, Monnerat G, Dill A Genes (Basel). 2024; 15(8).

PMID: 39202447 PMC: 11353293. DOI: 10.3390/genes15081088.


Sustainability of exercise-induced benefits on circulating MicroRNAs and physical fitness in community-dwelling older adults: a randomized controlled trial with follow up.

Huang L, Lim A, Hsu C, Tsai Y, Fu T, Shyu Y BMC Geriatr. 2024; 24(1):473.

PMID: 38816804 PMC: 11137894. DOI: 10.1186/s12877-024-05084-0.


Exercise-induced changes in left ventricular strain are affected by interleukin-6 activity: An exploratory analysis of a randomised-controlled trial in humans with abdominal obesity.

Jonck S, Lok M, Durrer C, Wedell-Neergaard A, Lehrskov L, Legaard G Exp Physiol. 2024; 109(7):1134-1144.

PMID: 38803062 PMC: 11215489. DOI: 10.1113/EP091800.


The Role and Potential Mechanisms of Rehabilitation Exercise Improving Cardiac Remodeling.

Gao H, Li Z, Gan L, Chen X J Cardiovasc Transl Res. 2024; 17(4):923-934.

PMID: 38558377 DOI: 10.1007/s12265-024-10498-7.


References
1.
Izumo S, Nadal-Ginard B, Mahdavi V . Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A. 1988; 85(2):339-43. PMC: 279543. DOI: 10.1073/pnas.85.2.339. View

2.
Frystyk J . Exercise and the growth hormone-insulin-like growth factor axis. Med Sci Sports Exerc. 2009; 42(1):58-66. DOI: 10.1249/MSS.0b013e3181b07d2d. View

3.
Golbidi S, Laher I . Exercise and the cardiovascular system. Cardiol Res Pract. 2012; 2012:210852. PMC: 3371347. DOI: 10.1155/2012/210852. View

4.
Li B, Setoguchi M, Wang X, Andreoli A, Leri A, Malhotra A . Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. Circ Res. 1999; 84(9):1007-19. DOI: 10.1161/01.res.84.9.1007. View

5.
Ooi J, Bernardo B, McMullen J . The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy. Future Med Chem. 2014; 6(2):205-22. DOI: 10.4155/fmc.13.196. View